Skip to content Skip to sidebar Skip to footer

Newsletter

Uncategorized

Imricor (ASX:IMR) Re Rates After FDA Clears NorthStar Mapping System

Imricor Wins FDA Clearance for NorthStar and Unlocks US Commercial Market Imricor (ASX:IMR) saw a strong re rating today after announcing that the US FDA has granted clearance for its NorthStar Mapping System. This is a meaningful milestone because NorthStar is the first and only MRI native 3D mapping and guidance system to receive FDA clearance.…

ByCharlie YouldenJanuary 29, 2026

High Stakes Investing: How Gambling Companies Perform on the Stock Market

Gambling companies are on the stock market, which makes them slightly odd. They mix entertainment, technology, regulation, and risk in ways that send share prices moving for reasons that feel emotional, political, and sometimes downright chaotic. A government announcement can wipe billions off a company's value even if the business itself hasn't changed at all. A…

ByUjjwal MaheshwariJanuary 21, 2026

5 radical ideas for the Australian capital markets from North America that could reinvigorate investor sentiment

Our article title '5 radical ideas for the Australian capital markets from North America what could reinvigorate investor sentiment' may cause some raised eyebrows. Do we really just want to 'copy North America'? Is investor sentiment really that bad that we need 'radical ideas' to reinvigorate investor sentiment? Didn't the ASX rise 6% in 2025? Look,…

ByNick SundichJanuary 21, 2026

Choosing the Right VPN for Australian Stock Market Research

Doing stock market research in Australia means handling sensitive information, logging into broker platforms, reading paywalled research and sometimes using public Wi-Fi while on the go. A good VPN for Australian market research isn't a luxury - it's a practical tool that helps protect your data and your decisions. This article explains why the right…

ByUjjwal MaheshwariJanuary 19, 2026

Why Trump Was Buying Netflix & Warner Company Bonds in December

Trump’s Bond Trades Hint at a Calculated Media Allocation An interesting disclosure has emerged from a recent White House financial filing, offering a rare glimpse into personal fixed income activity tied to President Donald Trump. The document outlines 191 bond purchase and sale transactions attributed to Trump. Among these, the filing shows purchases of Netflix bonds…

ByCharlie YouldenJanuary 19, 2026

4DMedical (ASX:4DX) What the Market Is Really Pricing In at A$5.40

What Retail Investors Need to Know Before Chasing the Story 4DMedical has quickly become one of the more talked about stocks in the market, and with that attention comes the need for clarity. In this piece, we want to break down the company’s latest investor presentation and what it really means for shareholders. That includes a…

ByCharlie YouldenJanuary 19, 2026

Is DroneShield (ASX:DRO) Australia’s Chosen LAND 156 LoE Defence Play

Australia’s Flagship Defence Tech Champions At the core of the DroneShield story, if investors have not already worked it out, is momentum. For small and mid cap companies that are approaching profitability and beginning to cross the commercialisation threshold, market momentum often becomes the dominant force driving share price performance. DroneShield is a clear example of…

ByCharlie YouldenJanuary 16, 2026

Terra Metals (ASX:TM1) This Is How Exploration Stories Get Bigger

Why This Was More Than Just Another Assay Result Terra Metals (ASX:TM1) has delivered an exceptional outcome for investors, with the stock up close to 400% over the past year. Momentum has continued following the release of the company’s first assay results from SW5, a target within the Southwest prospect area at the Dante Project. Importantly,…

ByCharlie YouldenJanuary 14, 2026

Catalina Resources (ASX:CTN) A Drill-Ready Story With Everything Still to Prove

Catalina Resources Chasing Copper at Breakaway Dam Catalina Resources is reshaping its portfolio through a strategic asset swap and targeted acquisition with Forrestania Resources, alongside the completion of a capital raise. The stock has had a strong run, up around 30% over the past month, but it is important to frame this in context. Catalina…

ByCharlie YouldenJanuary 13, 2026

Cochlear (ASX:COH) is still a long term growth story you should listen to

Cochlear is one of few stocks that has created immense shareholder value and has also greatly improved the lives of its users. Yes, this can be said with respect to many ASX health stocks, but this one can hang its hat on its societal impacts more than most other companies. What are the Best ASX Stocks…

ByNick SundichJanuary 9, 2026